Sinequan
This medication is indicated to address depression and anxiety-related symptoms and intended to support mood stabilization in patients.
Strengths: 10 · 25 · 75mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Tricyclic Antidepressant
- Pharmacological class
Tricyclic Antidepressant (TCA)
- Known off-label uses
insomnia
- Contraindications
urinary retention; narrow-angle glaucoma; concurrent use of MAO inhibitors
- Precautions and warnings
may cause drowsiness; caution in prostatic hypertrophy
- Minor side effects
dry mouth; blurred vision; constipation; drowsiness
- Moderate side effects
tachycardia; orthostatic hypotension
- Dosage forms
Capsule, hard
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
2–3 weeks
- Duration
long-term
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
Alcohol; Antihistamines; MAO inhibitors
- Age restrictions
Use with caution in elderly patients.
- Pregnancy and breastfeeding
Pregnancy: consult a doctor. Breastfeeding: not recommended.
Serious side effects
suicidal ideation — requires immediate medical attention; cardiac arrhythmia — requires immediate medical attention
Patient summary
This medication is indicated to address depression and anxiety-related symptoms and intended to support mood stabilization in patients.
Mechanism of action
Doxepin acts by inhibiting the reuptake of both serotonin and norepinephrine in the central nervous system synapses, thereby increasing their concentration and improving mood.
Sinequan
This medication is indicated to address depression and anxiety-related symptoms and intended to support mood stabilization in patients.
Editorial Notes
- Active ingredient(s): Doxepin
- Listed indication(s): Major Depressive Disorder, Anxiety
Usually available as
- 360 tablets - 10 mg98-10-mg-4193
- 90 tablets - 25 mg98-25-mg-4199
- 90 tablets - 75 mg98-75-mg-4207